會議主題: Track1: Biomarkers in Drug Development
• Biomarkers for drug safety assessment
• Translational biomarkers
• Personalized medicine Track2: Biomarkers in Molecular Diadnostics
• Biomarker assay development and translation
• Circulating tumor cells
• PGx biomarkers for patient selection Track3: Executive Summit: Drug-Diadnostics Co-Development
• Drug-diagnostic co-development challenges and case studies
• Partnering strategies
• Regulatory requirements for companion diagnostics